Cargando…
Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment
Lipid-structured vesicles have been applied for drug delivery system for over 50 years. Based on their origin, lipid-structured vesicles are divided into two main categories, namely synthetic lipid vesicles (SLNVEs) and vesicles of mammalian origin (MDVEs). Although SLNVEs can stably transport anti-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664809/ https://www.ncbi.nlm.nih.gov/pubmed/38026523 http://dx.doi.org/10.2147/IJN.S432279 |
_version_ | 1785148795644805120 |
---|---|
author | Zhao, Yuying Tan, Hanxu Zhang, Juping Pan, Bo Wang, Neng Chen, Tongkai Shi, Yafei Wang, Zhiyu |
author_facet | Zhao, Yuying Tan, Hanxu Zhang, Juping Pan, Bo Wang, Neng Chen, Tongkai Shi, Yafei Wang, Zhiyu |
author_sort | Zhao, Yuying |
collection | PubMed |
description | Lipid-structured vesicles have been applied for drug delivery system for over 50 years. Based on their origin, lipid-structured vesicles are divided into two main categories, namely synthetic lipid vesicles (SLNVEs) and vesicles of mammalian origin (MDVEs). Although SLNVEs can stably transport anti-cancer drugs, their biocompatibility is poor and degradation of exogenous substances is a potential risk. Unlike SLNVEs, MDVEs have excellent biocompatibility but are limited by a lack of stability and a risk of contamination by dangerous pathogens from donor cells. Since the first discovery of plant-derived vesicles (PDVEs) in carrot cell supernatants in 1967, emerging evidence has shown that PDVEs integrate the advantages of both SLNVEs and MDVEs. Notably, 55 years of dedicated research has indicated that PDVEs are an ideal candidate vesicle for drug preparation, transport, and disease treatment. The current review systematically focuses on the role of PDVEs in cancer therapy and in particular compares the properties of PDVEs with those of conventional lipid vesicles, summarizes the preparation methods and quality control of PDVEs, and discusses the application of PDVEs in delivering anti-cancer drugs and their underlying molecular mechanisms for cancer therapy. Finally, the challenges and future perspectives of PDVEs for the development of novel therapeutic strategies against cancer are discussed. |
format | Online Article Text |
id | pubmed-10664809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106648092023-11-18 Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment Zhao, Yuying Tan, Hanxu Zhang, Juping Pan, Bo Wang, Neng Chen, Tongkai Shi, Yafei Wang, Zhiyu Int J Nanomedicine Review Lipid-structured vesicles have been applied for drug delivery system for over 50 years. Based on their origin, lipid-structured vesicles are divided into two main categories, namely synthetic lipid vesicles (SLNVEs) and vesicles of mammalian origin (MDVEs). Although SLNVEs can stably transport anti-cancer drugs, their biocompatibility is poor and degradation of exogenous substances is a potential risk. Unlike SLNVEs, MDVEs have excellent biocompatibility but are limited by a lack of stability and a risk of contamination by dangerous pathogens from donor cells. Since the first discovery of plant-derived vesicles (PDVEs) in carrot cell supernatants in 1967, emerging evidence has shown that PDVEs integrate the advantages of both SLNVEs and MDVEs. Notably, 55 years of dedicated research has indicated that PDVEs are an ideal candidate vesicle for drug preparation, transport, and disease treatment. The current review systematically focuses on the role of PDVEs in cancer therapy and in particular compares the properties of PDVEs with those of conventional lipid vesicles, summarizes the preparation methods and quality control of PDVEs, and discusses the application of PDVEs in delivering anti-cancer drugs and their underlying molecular mechanisms for cancer therapy. Finally, the challenges and future perspectives of PDVEs for the development of novel therapeutic strategies against cancer are discussed. Dove 2023-11-18 /pmc/articles/PMC10664809/ /pubmed/38026523 http://dx.doi.org/10.2147/IJN.S432279 Text en © 2023 Zhao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Zhao, Yuying Tan, Hanxu Zhang, Juping Pan, Bo Wang, Neng Chen, Tongkai Shi, Yafei Wang, Zhiyu Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title | Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title_full | Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title_fullStr | Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title_full_unstemmed | Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title_short | Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment |
title_sort | plant-derived vesicles: a new era for anti-cancer drug delivery and cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664809/ https://www.ncbi.nlm.nih.gov/pubmed/38026523 http://dx.doi.org/10.2147/IJN.S432279 |
work_keys_str_mv | AT zhaoyuying plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT tanhanxu plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT zhangjuping plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT panbo plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT wangneng plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT chentongkai plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT shiyafei plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment AT wangzhiyu plantderivedvesiclesaneweraforanticancerdrugdeliveryandcancertreatment |